355 related articles for article (PubMed ID: 23933785)
21. Surgical outcomes and prognostic factors for ampulla of Vater cancer.
Choi SB; Kim WB; Song TJ; Suh SO; Kim YC; Choi SY
Scand J Surg; 2011; 100(2):92-8. PubMed ID: 21737384
[TBL] [Abstract][Full Text] [Related]
22. Significance analysis of histologic type and perineural invasion as prognostic factors after curative resection of ampulla of Vater carcinoma.
Lee JH; Lee KG; Ryou H; Jun YJ; Paik SS; Park HK; Lee KS
Hepatogastroenterology; 2010; 57(99-100):646-52. PubMed ID: 20698243
[TBL] [Abstract][Full Text] [Related]
23. Long-term results of surgical treatment of Vater's ampulla neoplasms.
Bucher P; Chassot G; Durmishi Y; Ris F; Morel P
Hepatogastroenterology; 2007 Jun; 54(76):1239-42. PubMed ID: 17629078
[TBL] [Abstract][Full Text] [Related]
24. Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection.
Qiao QL; Zhao YG; Ye ML; Yang YM; Zhao JX; Huang YT; Wan YL
World J Surg; 2007 Jan; 31(1):137-43; discussion 144-6. PubMed ID: 17171495
[TBL] [Abstract][Full Text] [Related]
25. Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.
Falconi M; Crippa S; DomÃnguez I; Barugola G; Capelli P; Marcucci S; Beghelli S; Scarpa A; Bassi C; Pederzoli P
Ann Surg Oncol; 2008 Nov; 15(11):3178-86. PubMed ID: 18712568
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic Antigen, CA19-9, Alpha-fetoprotein, CA72-4, and CA125) in Gastric Cancer.
Kim JH; Jun KH; Jung H; Park IS; Chin HM
Hepatogastroenterology; 2014 May; 61(131):863-9. PubMed ID: 26176088
[TBL] [Abstract][Full Text] [Related]
27. Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma.
Kim RD; Kundhal PS; McGilvray ID; Cattral MS; Taylor B; Langer B; Grant DR; Zogopoulos G; Shah SA; Greig PD; Gallinger S
J Am Coll Surg; 2006 Jan; 202(1):112-9. PubMed ID: 16377504
[TBL] [Abstract][Full Text] [Related]
28. Nodal involvement as an indicator of postoperative liver metastasis in carcinoma of the papilla of Vater.
Moriya T; Kimura W; Hirai I; Mizutani M; Ma J; Kamiga M; Fuse A
J Hepatobiliary Pancreat Surg; 2006; 13(6):549-55. PubMed ID: 17139430
[TBL] [Abstract][Full Text] [Related]
29. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
[TBL] [Abstract][Full Text] [Related]
30. Neutrophil to Lymphocyte Ratio Predicts Therapeutic Outcome After Pancreaticoduodenectomy for Carcinoma of the Ampulla of Vater.
Haruki K; Shiba H; Horiuchi T; Shirai Y; Iwase R; Fujiwara Y; Furukawa K; Misawa T; Yanaga K
Anticancer Res; 2016 Jan; 36(1):403-8. PubMed ID: 26722073
[TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of perineural invasion following pancreatoduodenectomy with lymphadenectomy for ampullary carcinoma.
Sudo T; Murakami Y; Uemura K; Hayashidani Y; Hashimoto Y; Ohge H; Shimamoto F; Sueda T
Dig Dis Sci; 2008 Aug; 53(8):2281-6. PubMed ID: 18095164
[TBL] [Abstract][Full Text] [Related]
32. Surgical management of neoplasms of the ampulla of Vater: local resection or pancreatoduodenectomy and prognostic factors for survival.
de Castro SM; van Heek NT; Kuhlmann KF; Busch OR; Offerhaus GJ; van Gulik TM; Obertop H; Gouma DJ
Surgery; 2004 Nov; 136(5):994-1002. PubMed ID: 15523392
[TBL] [Abstract][Full Text] [Related]
33. Important prognostic factors in adenocarcinoma of the ampulla of Vater.
Lowe MC; Coban I; Adsay NV; Sarmiento JM; Chu CK; Staley CA; Galloway JR; Kooby DA
Am Surg; 2009 Sep; 75(9):754-60; discussion 761. PubMed ID: 19774945
[TBL] [Abstract][Full Text] [Related]
34. Tumors of the ampulla of vater: histopathologic classification and predictors of survival.
Carter JT; Grenert JP; Rubenstein L; Stewart L; Way LW
J Am Coll Surg; 2008 Aug; 207(2):210-8. PubMed ID: 18656049
[TBL] [Abstract][Full Text] [Related]
35. Jaundice as a prognostic factor in patients undergoing radical treatment for carcinomas of the ampulla of Vater.
Zhou J; Zhang Q; Li P; Shan Y; Zhao D; Cai J
Chin Med J (Engl); 2014; 127(5):860-4. PubMed ID: 24571877
[TBL] [Abstract][Full Text] [Related]
36. Factors influencing lymph node metastasis in patients with ampullary adenocarcinoma.
Okano K; Asano E; Kushida Y; Kamada H; Mori H; Suzuki Y
Dig Surg; 2014; 31(6):459-67. PubMed ID: 25613423
[TBL] [Abstract][Full Text] [Related]
37. Tumor-related factors and patient's age influence survival after resection for ampullary adenocarcinoma.
Barauskas G; Gulbinas A; Pranys D; Dambrauskas Z; Pundzius J
J Hepatobiliary Pancreat Surg; 2008; 15(4):423-8. PubMed ID: 18670845
[TBL] [Abstract][Full Text] [Related]
38. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
39. Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value.
Kwon MJ; Kim JW; Jung JP; Cho JW; Nam ES; Cho SJ; Kim JS; Park HR; Min SK; Seo J; Min KW; Kim DH; Jeon JY
Hum Pathol; 2016 Apr; 50():90-100. PubMed ID: 26997442
[TBL] [Abstract][Full Text] [Related]
40. Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater.
Todoroki T; Koike N; Morishita Y; Kawamoto T; Ohkohchi N; Shoda J; Fukuda Y; Takahashi H
Ann Surg Oncol; 2003 Dec; 10(10):1176-83. PubMed ID: 14654474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
